In a 52-year-old male with a history of embolic cerebrovascular accident (stroke) presenting with several months of postprandial fullness, epigastric pain, and unintentional weight loss, and computed tomography (CT) with contrast showing gastric wall thickening and multiple enlarged regional lymph nodes, what diagnostic workup (laboratory tests, imaging, endoscopic procedures), differential diagnoses, and treatment options should be considered?

Diagnostic Workup and Management

This patient requires urgent upper endoscopy with extensive biopsies as the immediate next step to establish a tissue diagnosis, given the high suspicion for gastric malignancy based on CT findings of gastric wall thickening and enlarged lymph nodes. 1

Immediate Diagnostic Procedures

Endoscopy with Biopsy (Priority #1)

• Perform esophagogastroduodenoscopy with multiple biopsies from each region of the stomach, duodenum, gastroesophageal junction, and any abnormal-appearing sites 1, 2
• Obtain at least 6-8 biopsies from different gastric regions to maximize diagnostic yield
• Add endoscopic ultrasound (EUS) to evaluate:
  • Depth of gastric wall infiltration
  • Regional lymph node involvement
  • Helps distinguish T and N staging 1, 3

Essential Laboratory Tests

Order the following bloodwork immediately:

• Complete blood count (assess for anemia, which is common)
• Comprehensive metabolic panel (liver and renal function)
• Lactate dehydrogenase (LDH) and β2-microglobulin 1, 2
• H. pylori testing via histochemistry on biopsy specimens, or if negative, confirm with urea breath test and/or stool antigen test 1
• Serum protein immunofixation 1
• HIV, Hepatitis B and C serology 1

Staging Imaging

• CT chest, abdomen, and pelvis with contrast (already obtained, review carefully)
• Bone marrow aspirate and biopsy should be performed for complete staging 1, 2
• PET scan has limited utility and is not routinely recommended 2

Differential Diagnosis

Most Likely Diagnoses (in order of probability given presentation):

1. Gastric Adenocarcinoma (90% of gastric malignancies)

   • Classic presentation: postprandial fullness, epigastric pain, weight loss
   • Wall thickening and lymphadenopathy on CT highly suggestive
   • Peak incidence in seventh decade, more common in males 3

2. Gastric MALT Lymphoma (Marginal Zone Lymphoma)

   • Represents 7% of non-Hodgkin's lymphomas; one-third present as primary gastric lymphoma 1, 2
   • Presents with identical non-specific upper GI symptoms (postprandial fullness, epigastric pain, weight loss)
   • Often appears as non-specific gastritis or peptic ulcer on endoscopy, mass lesions unusual 1
   • Strongly associated with H. pylori infection
   • Critical to diagnose as treatment differs dramatically from adenocarcinoma

3. Diffuse Large B-Cell Lymphoma (gastric)

   • More aggressive presentation
   • May show larger mass lesions

4. Gastrointestinal Stromal Tumor (GIST)

   • Less likely given multiple enlarged lymph nodes (GISTs rarely metastasize to lymph nodes)
   • Can present with similar symptoms 4

5. Metastatic Disease to Stomach

   • Consider given history of embolic CVA (suggests possible underlying malignancy with hypercoagulability)

Treatment Approach (Depends on Diagnosis)

If Gastric MALT Lymphoma is Confirmed:

First-line treatment for localized H. pylori-positive gastric MALT lymphoma is H. pylori eradication with antibiotics alone 1, 5

• Use PPI-based triple therapy: PPI + clarithromycin + (amoxicillin or metronidazole) for 10-14 days 1
• Confirm eradication with urea breath test at least 6 weeks after treatment and at least 2 weeks after stopping PPI 1
• Wait up to 12 months for lymphoma regression before considering additional treatment if H. pylori is eradicated and patient achieves clinical/endoscopic remission 1, 2
• If H. pylori negative or antibiotic failure: consider involved-site radiotherapy (30-40 Gy) for stage I-II disease 1, 2
• For systemic disease: rituximab-based chemoimmunotherapy 5

Important caveat: Consider FISH or PCR for t(11;18) translocation—patients with this translocation are unlikely to respond to antibiotics and may need upfront radiotherapy or systemic therapy 1, 2

If Gastric Adenocarcinoma is Confirmed:

• Surgical resection is the only potentially curative treatment 3
• Requires multidisciplinary team evaluation (surgery, medical oncology, radiation oncology)
• Laparoscopy with peritoneal washings recommended for all stage IB-III cancers to detect occult peritoneal disease 3
• Combined modality therapy (surgery + chemotherapy ± radiation) is standard for ≥stage IB disease 3

Critical Clinical Pitfalls to Avoid

1. Do not assume gastric adenocarcinoma without tissue diagnosis—MALT lymphoma presents identically but has completely different treatment (antibiotics vs. surgery)

2. Do not skip H. pylori testing—even if histochemistry is negative on initial biopsies, confirm with serology, breath test, or stool antigen 1

3. Do not rush to surgery before complete staging—laparoscopy may reveal peritoneal disease that changes management entirely

4. In MALT lymphoma, do not treat persistent histologic disease after successful H. pylori eradication as treatment failure—molecular persistence of monoclonal B-cells is common and watchful waiting is appropriate if patient is asymptomatic 1, 2

5. Consider the embolic CVA history—this patient may have underlying atrial fibrillation or other cardioembolic source; ensure anticoagulation is optimized and consider whether gastric pathology could be related to embolic phenomena (though rare) 6, 7

Immediate Next Steps Algorithm

1. Urgent GI consultation → Schedule EGD with extensive biopsies + EUS within 24-48 hours
2. Order labs (CBC, CMP, LDH, β2-microglobulin, H. pylori testing, viral serologies)
3. Review existing CT with radiology for staging information
4. Once pathology returns (typically 3-5 days):
   • If MALT lymphoma → Check H. pylori status, order bone marrow biopsy, consider FISH for t(11;18)
   • If adenocarcinoma → Arrange laparoscopy, multidisciplinary tumor board discussion
5. Initiate treatment based on final diagnosis and staging